Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Other Working Capital Changes of $319000.0 for Q1 2026, up 126.3% year-over-year from $140964.3 in Q1 2025, and up 267.89% quarter-over-quarter from -$190000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Other Working Capital Changes for 17 consecutive years, with $319000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 126.3% year-over-year to $319000.0; the TTM figure through Mar 2026 stood at $775000.0 (up 147.11% YoY), while the FY2025 annual figure was -$757000.0, down 26.59% from the prior year.
- Other Working Capital Changes improved to $319000.0 in Q1 2026 per LXRX's latest filing, from -$190000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.0 million in Q2 2023 and bottomed at -$4.0 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged $71000.0 across 5 years, with a median of -$191000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 400.0% — and 2023, when it sank 1438.93%.
- Lexicon Pharmaceuticals' Other Working Capital Changes stood at -$1.1 million in 2022, then surged by 392.01% to $3.3 million in 2023, then slumped by 166.12% to -$2.2 million in 2024, then surged by 91.26% to -$190000.0 in 2025, then jumped by 267.89% to $319000.0 in 2026.
- Business Quant data shows LXRX's Other Working Capital Changes at $319000.0 in Q1 2026, -$190000.0 in Q4 2025, and -$191000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -716,000.00 |
| Jun 30, 2026 | -716,000.00 |
| Jun 30, 2026 | -716,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Dec 31, 2025 | -190,000.00 |
| Dec 31, 2025 | -190,000.00 |
| Dec 31, 2025 | -190,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Dec 31, 2024 | -2.17 Mn |